tbuckley/cabot-search huggingface dataset:
Guidelines for the Appropriate Use of Do-Not-Resuscitate Orders
Journal: JAMA (1991)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Whither Biomedical Research?
Journal: JAMA (1972)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Escherichia Coli capsular polysaccharide and spontaneous bacterial peritonitis in cirrhosis
Authors: G SORIANO
Journal: Hepatology (1995)

Spontaneous bacterial peritonitis (SBP) is a frequent and severe complication of cirrhosis. Escherichia coli is the most frequent bacterium isolated in this condition. The presence of capsular antigens, mainly the K1 capsular polysaccharide, has been associated with invasiveness in E coli infections. Capsular serotypes of E coli causing SBP were determined in 37 cirrhotic patients. Twenty-seven strains were encapsulated (72.9%), 9 of them (24.3%) with K1 capsular polysaccharide, and 10 were nonencapsulated. Patients with encapsulated E coli showed a significantly higher incidence (92.5% vs. 50%; P < .01) and number of complications per patient (1.9 ± 1.1 vs. 0.8 ± 1.0; P < .01) than patients with nonencapsulated strains. Although mortality was higher in patients with encapsulated strains (44.4% vs. 20%), the difference did not reach statistical significance. Considering patients infected by encapsulated strains, the incidence of complications and mortality were similar in patients with or without K1 strains. These data suggest that the presence of encapsulated strains could have a prognostic significance in SBP caused by E coli in cirrhotic patients.
Address.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
MENTHOL AND PEPPERMINT IN ACUTE CATARRHAL CONDITIONS OF THE RESPIRATORY TRACT
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The National Formulary of Unofficial Preparations. Revised edition.
Journal: JAMA (1896)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Intimal thickness one year after cardiac transplantation is a strong predictor of long term clinical outcome: A serial intravascular ultrasound study Ravish Sachar, Samir R. Kapadia, Khaled M. Ziada, Navdeep Boparai, Luba Platt, Timothy D. Crowe, Robert E. Hobbs, Steven E. Nissen, E. Murat Tuzcu. The Cleveland Clinic Foundation, Cleveland, OH
Journal: Journal of the American College of Cardiology (2001)
Liver Function Tests among Michigan and Wisconsin Dairy Farmers
Authors: Henry A. Anderson, Edwin C. Holstein, Susan M. Daum, Laszlo Sarkozi, Irving J. Selikoff
Journal: Environmental Health Perspectives (1978)

Serum activity of SGOT, SGPT, LDH, and alkaline phosphatase was measured in 614 Michigan adults exposed to PBB and 141 Wisconsin adults not so exposed. The Michigan group had higher prevalence of abnormal SGOT (p less than 0.005) and SGPT (p less than 0.005). A clear sex difference was observed. Michigan men had a higher prevalence of abnormal SGPT (p less than 0.005) and LDH (p less than 0.005) than Michigan women, and a higher prevalence than Wisconsin men of abnormal SGOT (p less than 0.005) and SGPT (p less than 0.01). These differences could not be ascribed to differing patterns of alcohol consumption, laboratory error, or choice of criteria for normality/abnormality. Seven Michigan subgroups were defined on the basis of the criteria by which they had been selected to participate. The two subgroups who were essentially self-invited did not differ from the remaining five randomly selected subgroups combined in prevalence of these abnormal liver function tests. Based on 364 serum PBB analyses thus far analyzed of the 614 Michigan participants, no obvious relationship between serum PBB values and liver function tests was observed. However, this is a tentative conclusion that will be further evaluated when remaining serum PBB analyses are completed. The greater prevalence of abnormal SGPT and SGOT among Michigan dairy farm residents compared to the Wisconsin dairy farm residents is tentatively ascribed to the former group's exposure to PBB.
Abstract 405: Bcl-xL Serine 14 Phosphorylation is Critical for Pressure Overload-induced Cardiac Hypertrophy
Authors: Michinari Nakamura, Nadezhda Fefelova, Lai-Hua Xie, Peiyong Zhai, Shohei Ikeda, Junichi Sadoshima
Journal: Circulation Research (2017)

Cardiac hypertrophy is an adaptive response to various stresses, wherein Ca 2+ serves as a messenger to induce hypertrophy. We found that phosphorylation of Bcl-xL at Serine (Ser) 14 is significantly increased in the heart within one hour after transverse aortic constriction (TAC)-induced pressure overload. However, the functional significance of the increased Ser14-phosphorylation in hypertrophy is unknown. To address this question, wild-type (WT) and phosphorylation-resistant knock-in (KI) mice with an Alanine mutation at Ser14 in the Bcl-x gene were subjected to TAC. The KI mice had significantly higher mortality than WT mice (p=0.001), accompanied by heart failure (LVEDP, 34.6 vs 16.5 mmHg, p&lt;0.05) with contractile dysfunction (EF, 38.2% vs 67.5%, p&lt;0.001) and increased fibrosis (1.6-fold, p&lt;0.001). Although the level of apoptosis was similar between the KI and WT mice one week after TAC, as assessed by TUNEL staining and cleaved caspase 3 and 9 expressions, cardiomyocyte and cardiac hypertrophy were inhibited in the KI mice (cardiomyocyte size, 0.32-fold; heart weight/tibia length, 0.61-fold, both P&lt;0.001). Consistent with this finding, ANP and BNP gene expressions were significantly suppressed in the KI mice despite worse cardiac function (0.17-fold (p&lt;0.001) and 0.69-fold (p&lt;0.05), respectively). Adult cardiomyocytes isolated from the KI mice two days after TAC showed significantly reduced contractility compared to those isolated from WT mice (0.32-fold, p&lt;0.001). Mechanistically, gene set enrichment analysis using the RNA-seq data obtained from the mouse heart one day after TAC revealed significantly altered channel activity in the KI mice. Although angiotensin II (AngII) increases Ser14-phosphorylation and cytosolic Ca 2+ level in WT-MEFs in vitro , MEFs isolated from the KI mice showed a significantly lower elevation of cytosolic Ca 2+ against AngII stimulation. Taken together, these data suggests that Bcl-xL-Ser14 phosphorylation promotes Ca 2+ release from the sarcoplasmic reticulum in response to pressure overload or AngII stimulation, leading to compensatory hypertrophy. Our findings indicate that targeting the Bcl-xL-Ser14 phosphorylation could be a potential therapeutic strategy for acute heart failure.
Cabozantinib Approved for Renal Cell Carcinoma
Journal: Cancer Discovery (2016)

Abstract The FDA has approved cabozantinib, a tyrosine kinase inhibitor, for patients with advanced renal cell carcinoma who have received prior antiangiogenic therapy. In a randomized phase III trial, participants who received cabozantinib did better across three efficacy endpoints—progression-free survival, overall survival, and objective response rate—than those given the mTOR inhibitor everolimus.
The Law of Cremation: An Outline of the Law relating to Cremation, Ancient and Modern.
Journal: JAMA (1893)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Mothers' Guide When Sickness Comes
Journal: JAMA (1935)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SportsMedUpdate
Authors: Martin P Schwellnus
Journal: British Journal of Sports Medicine (2011)

1. Buist I, 2. Bredeweg SW, 3. Lemmink KAPM, 4. van Mechelen W, 5. Diercks RL . Predictors of runningrelated injuries in novice runners enrolled in a systematic training programme. Am J Sports Med 2010;38:273–80. [OpenUrl][1][Abstract/FREE Full Text][2] ### Background: Running is an important recreational and health-promoting physical activity; however, it is associated with a significant risk of injury and therefore risk factors related to running injuries deserve investigation. ### Research question/s: What are the predictors for running-related injuries (RRI) and are these different in male versus female novice runners? ### Methodology: Subjects: 532 novice runners (male 226, female 306) who were training over 13 weeks to run a 6.7-km event. Experimental procedure: All the subjects were assessed before the onset of training (baseline questionnaire and orthopaedic examination) and were then followed for self-reported running-related musculoskeletal pain (lower extremity or back, causing a restriction of running for at least 1 week). The incidence of RRI during the period was 21%. Measures of outcome: Multivariate adjusted Cox regression model (HR) to determine the risk factors for RRI in men and women. ### Main finding/s: HR for RRI in novice female runners: an increased navicular drop (measure of foot pronation) (HR 0.85; 95% CI 0.75 to 0.97) was a significant predictor for RRI. Other variables (type A behaviour, hip and ankle range of motion) were nor predictors of RRI in novices. ### Conclusion/s: In a prospective, cohort study of novice runners, different risk factors for RRI were identified in male (increased body mass index, previous injury, previous sports participation) … [1]: {openurl}?query=rft.jtitle%253DAm%2BJ%2BSports%2BMed%26rft_id%253Dinfo%253Adoi%252F10.1177%252F0363546509347985%26rft_id%253Dinfo%253Apmid%252F19966104%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/ijlink?linkType=ABST&journalCode=amjsports&resid=38/2/273&atom=%2Fbjsports%2F45%2F5%2F460.atom
A SIMPLE METHOD OF DRAINAGE TUBE FIXATION
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Massive pseudoproteinuria caused by nafcillin
Authors: D. E. Line
Journal: JAMA (1976)

RECENTLY, we saw two patients in whom a heavy concentration of urinary protein reported from the laboratory was eventually proved to be a false-positive result, representing not protein but nafcillin excreted in the urine. <h3>Report of Cases</h3><h3>Case 1.—</h3> A 13-year-old boy with staphylococcal osteomyelitis of the left femur was treated intravenously with 12 gm of nafcillin sodium daily. Shortly thereafter his urine showed 4+ protein reaction on routine analysis with sulfosalicylic acid. Renal function, as measured by blood urea nitrogen (BUN) value, serum creatinine level, and creatinine clearance, was within normal limits. Protein level in a 24-hour urine sample (measured by the standard trichloroacetic acid method) was 3.9 gm. Results of urine-sediment examination were unremarkable, showing no free fat, oval fat bodies, or fatty casts. Subsequent protein testing on several occasions with sulfosalicylic acid again revealed 3+ to 4 + protein reaction, but a dipstick specific for albumin gave a
National transplant communications network
Authors: P. I. Terasaki
Journal: JAMA (1971)

A National Communications Network for cadaver kidney transplant sharing in the United States and Canada has been established and has been functional for 1 1/2 years. Currently, a total of 864 waiting recipients from 61 transplant centers are kept on the computerized file. Through this network a total of 215 kidneys have been exchanged; 40 kidneys originated from nontransplanting hospitals and 175 from transplant centers. This type of interhospital cooperation for the treatment of patients is a new development and is essential for the complete utilization of valuable organs and for the development and evaluation of histocompatibility methods in transplantation.
More About: Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations
Authors: F. Eisinger, J. Jacquemier, E. Charafe-Jauffret, M.-C. Rio, D. Birnbaum, H. Sobol
Journal: JNCI Journal of the National Cancer Institute (1999)
Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular Carcinoma
Authors: Martin F. Sprinzl, Martha M. Kirstein, Sandra Koch, Marie-Luise Seib, Julia Weinmann-Menke, Hauke Lang, Christoph Düber, Gerrit Toenges, Daniela Zöller, Jens U. Marquardt, Marcus-Alexander Wörns, Peter R. Galle, Arndt Vogel, Matthias Pinter, Arndt Weinmann
Journal: Liver Cancer (2018)

Inflammation affects progression of hepatocellular carcinoma (HCC). We therefore postulate that systemic inflammatory markers could help to predict prognosis in HCC patients receiving sorafenib therapy.Overall survival (OS) of HCC patients receiving palliative sorafenib treatment was correlated with the neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), C-reactive protein to albumin ratio (CAR), Glasgow prognostic score (GPS) and the modified GPS (mGPS) along with clinicopathological parameters. Predictors of OS were assessed by multivariable Cox regression and receiver operating characteristics and area under the curve (ROC-AUC) analyses.Patients receiving sorafenib (n = 120) for advanced HCC (Barcelona Clinic Liver Cancer stage C) were explored by retrospective analysis. Findings were subsequently validated by a second HCC cohort (n = 113) receiving sorafenib at two independent treatment centers. Multivariable assessment across these HCC cohorts confirmed a stable association of CAR (p ≤ 0.001), GPS (p ≤ 0.01) and mGPS (p ≤ 0.004) with OS. This study also identified Eastern Cooperative Oncology Group (ECOG) performance score (p < 0.001) and portal thrombosis (p = 0.002) as prognostic factors and uncovered an inconsistent OS association of NLR and PLR in HCC patients. Additional combined analysis of ECOG, portal thrombosis and GPS within an extended score (GPS-EP) was associated with OS (p = 0.021), which was confirmed within the validation cohort (p = 0.001). In sorafenib-treated HCC, the ROC-AUC value for the prediction of 12-month survival was 0.761 (CAR >/≤0.37 cut-off, p < 0.001), 0.766 (GPS, p < 0.001) and 0.754 (mGPS, p < 0.001), respectively. In comparison to this, GPS-EP achieved a higher AUC of 0.826 (0.746-0.907) for the 12-month survival prediction, resulting in a 64.4% sensitivity and 83.3% specificity at a > 2 point cut-off.Inflammatory scores obtained before sorafenib treatment initiation are associated with OS in advanced HCC. Their combination with other risk factors improves prediction of 3- and 12-month survival, which could guide treatment decisions in selected patient subgroups.
Book Review A Clinical and Experimental Investigation of the Blood Cholesterol Content in Myxoedema and Other Conditions . By E. H. Stokes, M.B., Ch.M. (Sydney), F.R.A.C.P. 4°, cloth, 121 pp., with 13 illustrations. Sydney: Australasian Medical Publishing Company, Limited, 1941.
Journal: New England Journal of Medicine (1944)